Massage for Newborns Receiving Nasal CPAP
Launched by SULTAN BESIKTAS · Apr 8, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the effects of massage on newborns who are receiving a type of breathing support called nasal CPAP. This treatment is often necessary for babies experiencing breathing difficulties, but it can sometimes lead to discomfort and stress. Researchers want to see if massage can help make these babies feel more comfortable and reduce their stress while they are in the neonatal intensive care unit (NICU).
To participate in the trial, newborns need to be over 34 weeks old, weigh at least 2000 grams, and have started nasal CPAP within the first 24 hours. Babies must also be healthy without any major birth complications. Parents will need to give their consent for their baby to take part. Throughout the study, participants can expect to receive gentle massage as part of their care, and the researchers will monitor how it affects their breathing, heart rate, and overall comfort. This trial is not yet recruiting participants, but it aims to provide valuable insights into improving care for newborns in the NICU.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Gestational age greater than 34 weeks
- • 2. Birth weight of 2000 g and above,
- • 3. Within the first 24 hours of nasal CPAP application
- • 4. Fed at least one hour before the procedure,
- • 5. Having no congenital anomaly,
- • 6. Not having any disease at birth such as neonatal asphyxia, hemolytic condition, patent ductus arteriosus (PDA),
- • 7. Those who have not undergone a surgical operation,
- • 8. The mother does not have alcohol, cigarette or other drug addiction,
- • 9. These are newborns to whom one of the parents (mother or father) has given verbal and written consent.
- Exclusion Criteria:
- • 1. Rh and ABO incompatibility,
- • 2. APGAR score below 6,
- • 3. Analgesic or anesthetic medication is administered for sedation,
- • 4. Saliva sample cannot be taken,
- • 5. NEC developing,
- • 6. Leaving the hospital before the end of the working period,
- • 7. Having had maternal obstetric complications,
- • 8. Receiving blood transfusion during the study,
- • 9. Newborns whose parents wish to withdraw from the study will not be accepted.
About Sultan Besiktas
Sultan Besiktas is a dedicated clinical trial sponsor focused on advancing innovative medical research to improve patient outcomes. With a commitment to ethical practices and rigorous scientific standards, Sultan Besiktas collaborates with leading healthcare professionals and institutions to design, implement, and manage clinical trials across various therapeutic areas. The organization prioritizes patient safety and data integrity, leveraging cutting-edge methodologies to contribute to the development of effective therapies and treatments. Through its strategic partnerships and commitment to excellence, Sultan Besiktas aims to drive advancements in healthcare and enhance the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Meral Bayat
Study Director
TC Erciyes Universty
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported